Gilbert, Richard J.
Siamwala, Jamila H.
Kumar, Vivek
Thompson, Christopher C.
Shikora, Scott A.
Article History
Accepted: 11 January 2023
First Online: 1 April 2023
Declarations
:
: RJG, JHS, VK, and SAS have no conflicts or appearances of conflict to report relevant to the content of this manuscript. CCT discloses the following potentially competing interests related to endoscopic treatments for GI disorders, including research support/consulting from Apollo Endo-surgery, Aspire Bariatrics, Boston Scientific, Erbe, GI Dynamics, Lumendi, Olympus, USGI Medical, and Covidien/Medtronic, as well as equity interest in Enterasense and Envision.
: This article does not contain any studies with human or animal subjects performed by any of the authors.